Morgan Stanley Htg Molecular Diagnostics, Inc Transaction History

Morgan Stanley

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$0.62 - $1.89 $364 - $1,111	588 Added 5.87%	10,611 $7,000
Q2 2022 Oct 27, 2022	SELL	$0.46 - $1.45 $2,180 - $6,873	-4,740 Reduced 32.11%	10,023 $10,000
Q2 2022 Aug 15, 2022	SELL	$0.46 - $1.45 $2,180 - $6,873	-4,740 Reduced 32.11%	10,023 $10,000
Q1 2022 Oct 27, 2022	BUY	$1.39 - $5.51 $6,588 - $26,117	4,740 Added 47.29%	14,763 $21,000
Q1 2022 May 13, 2022	BUY	$1.39 - $5.51 $16,586 - $65,750	11,933 Added 421.66%	14,763 $21,000
Q4 2021 Feb 14, 2022	SELL	$3.23 - $5.97 $4,486 - $8,292	-1,389 Reduced 32.92%	2,830 $15,000
Q3 2021 Nov 15, 2021	BUY	$5.01 - $6.8 $21,137 - $28,689	4,219 New	4,219 $24,000

Ticker HTGM
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 11,048,100
Market Cap $3.76M
Description
HTG Molecular Diagnostics, Inc. a life sciences company, focuses on the precision medicine. The company offers instruments; consumables comprising assay kits; and software that automate sample processing and profiles various molecular targets. Its marketed molecular profiling panels include HTG Transcriptome Panel; HTG EdgeSeq precision immuno-o...

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

Stay updated on Morgan Stanley with notifications on news.